| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |